ARP 101
SIGMA/A8356 - ≥98% (HPLC), solid
Synonym: (2R)-2-[([1,1′-Biphenyl]-4-ylsulfonyl)(1-methylethoxy)amino]-N-hydroxy-3-methyl-butanamide; (R)
CAS Number: 849773-64-4
Empirical Formula (Hill Notation): C20H26N2O5S
Molecular Weight: 406.50
MDL Number: MFCD09753277
Linear Formula: C20H26N2O5S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | solid |
| InChI | 1S/C20H26N2O5S/c1-14(2)19 |
| InChI key | DGZZVIWCMGVHGV-LJQANCHMSA |
| Quality Level | 100  |
| SMILES string | CC(C)ON([C@H](C(C)C)C(=O) |
| solubility | DMSO: >20 mg/mL |
| H2O: insoluble | |
| storage temp. | −20°C |
| Application: | ARP 101 is a MMP-2 selective inhibitor. ARP 101 has diverse physiological roles including wound healing, cancer metastasis, angiogenesis, tissue remodeling in development, and embryogenesis. |
| Biochem/physiol Actions: | ARP 101 is a MMP-2 selective inhibitor (Gelatinase A, EC 3.4.24.24; TBE-1; LG4A; MONA; Type IV Collagenase). ARP 101 has diverse physiological roles including wound healing, cancer metastasis, angiogenesis, tissue remodeling in development and embryogenesis. IC50 = 0.81 nM on MMP-2. |
| Biochem/physiol Actions: | ARP 101 is a MMP-2 selective inhibitor. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P301 + P310 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |